Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 3/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.47 |
| ▸ | FYN | P06241 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
| ▸ | APEX1 | P27695 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | MTOR | P42345 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30319438 | 1.00 | ALDH1A1 (0.59) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL16189491 | 0.86 | ESR1 (0.61) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL17504871 | 0.82 | APP (0.43) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL31292258 | 0.82 | APP (0.58) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL29531941 | 0.82 | ALDH1A1 (0.57) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL22619519 | 0.82 | ALDH1A1 (0.57) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL10483821 | 0.82 | ALDH1A1 (0.57) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| Hydrogen Peroxide SCHEMBL28263775 | 0.82 | ALDH1A1 (0.57) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL1805555 | 0.82 | ALDH1A1 (0.57) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL11552788 | 0.81 | HSP90AA1 (0.44) | ALDH1A1HPGDALOX15HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250073193-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM LTD (IL) | 2025-03-06 | — | — | US | claimed |
| EP-4299128-A2 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | Neuroderm Ltd. (IL) | 2024-01-03 | — | — | EP | claimed |
| EP-3777833-B1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM LTD (IL) | 2023-10-18 | — | — | EP | claimed |
| US-20230096364-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM LTD (IL) | 2023-03-30 | — | — | US | claimed |
| EP-3777833-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | Neuroderm Ltd (IL) | 2021-02-17 | — | — | EP | claimed |
| US-20210000777-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM LTD (IL) | 2021-01-07 | — | — | US | claimed |
| EP-3116475-B1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM LTD (IL) | 2020-11-04 | — | — | EP | claimed |
| US-10813902-B2 | DOPA decarboxylase inhibitor compositions | NEURODERM, LTD. (IL) | 2020-10-27 | — | — | US | claimed |
| US-10624839-B2 | Dopa decarboxylase inhibitor compositions | NEURODERM, LTD. (IL) | 2020-04-21 | — | — | US | claimed |
| US-20200046665-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM LTD (IL) | 2020-02-13 | — | — | US | claimed |
| US-20190151233-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM, LTD. (IL) | 2019-05-23 | — | — | US | claimed |
| US-10258585-B2 | DOPA decarboxylase inhibitor compositions | NEURODERM, LTD. (IL) | 2019-04-16 | — | — | US | claimed |
| US-10022320-B2 | Dopa decarboxylase inhibitor compositions | NEURODERM, LTD. (IL) | 2018-07-17 | — | — | US | claimed |
| US-20170157079-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM, LTD. (IL) | 2017-06-08 | — | — | US | claimed |
| EP-3116475-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | Neuroderm Ltd (IL) | 2017-01-18 | — | — | EP | claimed |
| US-20150352212-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM, LTD. (IL) | 2015-12-10 | — | — | US | claimed |
| WO-2015136538-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM LTD (IL) | 2015-09-17 | — | — | WO | claimed |
| US-20260102334-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM LTD (IL) | 2026-04-16 | — | — | US | disclosed |
| US-20150352212-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM, LTD. (IL) | 2015-12-10 | — | — | US | disclosed |
| WO-2015136538-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM LTD (IL) | 2015-09-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230096364-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | DDT, DDC, COMT | ALDH1A1 339/4885HPGD 372/4885ALOX15 1051/4885 |
| US-20210000777-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | DDT, DDC, COMT | ALDH1A1 339/4885HPGD 372/4885ALOX15 1051/4885 |
| US-20170157079-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | DDT, DDC, COMT | ALDH1A1 339/4885HPGD 372/4885ALOX15 1051/4885 |
| US-10813902-B2 | DOPA decarboxylase inhibitor compositions | DDT, DDC, COMT | ALDH1A1 339/4885HPGD 372/4885ALOX15 1051/4885 |
| US-20200046665-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | DDT, DDC, COMT | ALDH1A1 339/4885HPGD 372/4885ALOX15 1051/4885 |
| US-20260102334-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | COMT, PARK7, DDT | ALDH1A1 137/4885HPGD 78/4885ALOX15 1382/4885 |
| US-10258585-B2 | DOPA decarboxylase inhibitor compositions | DDT, DDC, COMT | ALDH1A1 339/4885HPGD 372/4885ALOX15 1051/4885 |
| US-20250073193-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | DDT, DDC, COMT | ALDH1A1 339/4885HPGD 372/4885ALOX15 1051/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.